To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

February 1, 2014 updated by: Hackensack Meridian Health
The goal for COPD patients in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of sleep disorders in COPD patients. We plan to further study these patients using questionnaires. A preliminary study was done, but the results were not comparable to national statistics. We plan to repeat the study, only changing the questions to a format comparable to data from the National Sleep Foundation.

Study Overview

Status

Completed

Conditions

Detailed Description

Hackensack University Medical Center Institutional Review Board

PROTOCOL: To study the prevalence of insomnia in geriatric COPD patients who are enrolled in a pulmonary rehabilitation program.

I. OBJECTIVES OF THE STUDY

RATIONALE:

The goal for geriatric patients with COPD and enrolled in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older, and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of difficulty initiating and maintaining sleep in COPD patients. A preliminary study was done by the chest medicine specialist in our group, but the results were not comparable to national statistics and were inconclusive. We plan to further evaluate the geriatric COPD patients in pulmonary rehabilitation with initial screening questionnaire and diagnostic screening questionnaires (MMSE, Beck's Anxiety Inventory, Beck's Depression Inventory, and Epworth Sleepiness Scale).

GOALS:

  • To determine the incidence and prevalence of insomnia (difficulty initiating sleep (DIS), and/or difficulty maintaining sleep (DMS) in the geriatric population with COPD in a rehabilitation program.
  • To determine how many of these patients suffer from anxiety and/or depression.

HYPOTHESIS:

The incidence of insomnia (DIS and/or DMS), along with anxiety/depression is more prevalent in geriatric patients with COPD.

II. BACKGROUND MATERIAL According to the American Academy of Sleep Medicine (AASM), over a six-month period, 20 million Americans complained of insomnia.

COPD patients tend to have decreased total sleep time (32% reported total sleep time less than 6 hours). According to previous studies conducted, the following was reported:

  • 15% reported to have insomnia;
  • 28% reported poor quality sleep due to anxiety and/or depression;
  • 12% reported > 3 awakenings due to unknown origin.

RESULTS OF PILOT:

In the pilot study, a preliminary general (initial) questionnaire was used and will continue to be used as a tool for general screening purposes. And diagnostic questionnaires will be used, which are the following:

  • Beck's Anxiety Inventory
  • Beck's Depression Inventory
  • Epworth Sleepiness Scale
  • MMSE

III. DRUG INFORMATION

No drugs are used in this study protocol.

IV. INCLUSIONARY CRITERIA

Geriatric patients with COPD enrolled in the rehabilitation program with FEV1<60%.

V. EXCLUSIONARY CRITERIA

Geriatric patients without a clear diagnosis of COPD. Geriatric patients whose FEV1>60%. Geriatric patients who are unable to answer the questionnaire.

VI. RECRUITMENT PROCEDURES

Geriatric patients in the HUMC pulmonary rehabilitation program who consent to answer the questionnaire and with an FEV1<60% will be enrolled.

VII. METHODOLOGY

Screening: Charts will be reviewed to see which patients meet the criteria of the study.

Informed Consent: If the patient is eligible for diagnostic screening, then an informed consent will be taken.

Randomization: None

Baseline evaluation: Geriatric patients will be asked the questions in the questionnaire.

Follow-up: If insomnia is found, patient will be referred for further treatment.

Withdrawal and Termination: The patient is unable to complete the questionnaire.

VIII. DISCOMFORT AND RISKS

No direct risks to the patient. Failure to follow-up in the clinic if indicated could be problematic.

IX. BENEFITS

Recognition and treatment of sleep problems in this group of patients will add to our understanding of problems in COPD.

X. CRITERIA FOR EVALUATING RESPONSE

No response anticipated from the study protocol.

XI. CONFIDENTIALITY

All results will be kept confidential. Data will only be used by the investigators. Data can be reviewed by the IRB at any time. HIPPA forms will be used for the patient's permission.

XII. PRIMARY INVESTIGATOR

Hormoz Ashtyani, M.D.

CO PRIMARY INVESTIGATOR

Susan Zafarlotfi Ph.D

GERIATRIC MEDICINE SPECIALIST

Knight R. Steel, M.D.

RESEARCH COORDINATOR

Mohammad Quadri, M.D. (MBA) RPSGT

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Hackensack University Medical Center - Pulmonary Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Greitric COPD patients who are enrolled in Pulmonary Rehabilitation at HUMC

Description

Inclusion Criteria:

  • COPD
  • rehabilitation program
  • FEV1<60%

Exclusion Criteria:

  • FEV1>60%

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hormoz Ashtyani, MD, Hackensack Meridian Health
  • Principal Investigator: Susan Zafarlotfi, Ph.D, Hackensack Meridian Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2006

Primary Completion (Actual)

May 1, 2008

Study Completion (Actual)

May 1, 2008

Study Registration Dates

First Submitted

June 28, 2006

First Submitted That Met QC Criteria

June 28, 2006

First Posted (Estimate)

June 30, 2006

Study Record Updates

Last Update Posted (Estimate)

February 4, 2014

Last Update Submitted That Met QC Criteria

February 1, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

3
Subscribe